Showing results (1-10 of 55) with videos related to
Sort By:
Pageof 6
Therapie|May 1, 1992
[Tolerance of famotidine. Study of network of sentinel physicians in pharmaco-vigilance]R M Chichmanian, G Mignot, A Spreux, et al.Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine|September 3, 1999
[Pharmacovigilance in practice]A Spreux, B Baldin, R M ChichmanianTherapie|September 1, 1992
[Economic impact of adverse drug effects. Some reflections]A Spreux, R M Chichmanian, A CastotTherapie|March 1, 1991
[Hypersensitivity to hypoglycemic sulfonylurea compounds. Are there cross-reactions?]R M Chichmanian, G Papasseudi, S Hieronimus, et al.Therapie|September 1, 1992
[Comparative study of data banks on drug interactions]C Barla, G Mignot, R M ChichmanianTherapie|September 1, 1993
[Risk related to withdrawal from non-psychotropic drugs]R M Chichmanian, P Gustovic, A Spreux, et al.Therapie|September 1, 1991
[Prospective OMEGA survey (Drug use-pregnancy relationship survey at the French Riviera)]A Spreux, R M Chichmanian, C Jean-Girard, et al.Therapie|September 1, 1990
[Financial analysis of hospitalizations for adverse effects of drugs. The economic role of the Regional Pharmacovigilance Center]G Mignot, J Biaggi, P Lethurgez, et al.Therapie|September 1, 1992
[Thrombopenia due to pefloxacin (Peflacine): dose-dependent toxicity?]R M Chichmanian, A Spreux, E Bernard, et al.Annales D'Endocrinologie|October 12, 2010
Birth defects observed with maternal carbimazole treatment: Six cases reported to Nice's Pharmacovigilance CenterD Koenig, A Spreux, S Hiéronimus, et al.Pageof 6